Study Group: Oncologists in the U.K.(?)
Council Members in this Study Group: 140
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Oncologists (EU) | 755 |
| Physicians who Treat CML (EU) | 135 |
| Oncologists who Treat Leukemia (EU) | 140 |
| Hematologists (EU) | 352 |
| Lung Cancer Oncologists (EU) | 46 |
| Urologists (EU) | 161 |
| Council Members who Treat Colon/Colorectal Cancer | 183 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Analysis of:
Tamoxifen: Some Women Don't Get Full Benefit | www.cancer.org
Gene discovery may explain why Tamoxifen is not effective in all women. This knowledge may allow novel approach to treatment re-dosage scheduling etc.Since AIs are relatively new, the long term risks may not yet be fully known, and since overall survival benefit is similar to Tamoxifen, it may be there...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Government/Military Hospital or Clinic
- Academic Institution*
- Non-Academic Community Hospital or Clinic
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Physician - Attending Physician
- Lecturer
- Professor
- Physician - Division Head
- Director
GLG's 850+ Clients Include:
Fortune 500®
companies
40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
global private equity firms
5 of the top 10
AmLaw firms